EZElisa™鞘氨醇1-磷酸受体5（S1 PR 5）试剂盒
-EZElisa™ Sphingosine 1-phosphate receptor 5 (S1PR5) Kit- 询价
- Biogradetech
- 美国
- A-QEK01029-96wells
- 2025年07月10日
企业认证
相关产品推荐更多 >
Sheep Cystatin B ELISA Kit/Sheep Cystatin B ELISA Kit
询价
EZElisa™大鼠异柠檬酸脱氢酶1（IDH1）ELISA试剂盒-EZElisa™ Rat Isocitrate Dehydrogenase 1, Soluble (IDH1) ELISA Kit
询价
Rat Protein Kinase B Gamma ELISA Kit/Rat Protein Kinase B Gamma ELISA Kit
询价Sheep Adiponectin Receptor 2 ELISA Kit/Sheep Adiponectin Receptor 2 ELISA Kit
询价
EZElisa ™ H2 A组蛋白家族,成员X（H2AFX）套件-EZElisa™ H2A Histone Family, Member X (H2AFX) Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
运输过程中保存：2-8℃
- 保质期：
1年
- 英文名：
EZElisa™ Sphingosine 1-phosphate receptor 5 (S1PR5) Kit
- 库存：
100
- 供应商：
艾美捷科技
EZElisa™鞘氨醇1-磷酸受体5（S1 PR 5）试剂盒，EZElisa™ Sphingosine 1-phosphate receptor 5 (S1PR5) Kit，鞘氨醇1-磷酸受体5（S1 PR 5）试剂盒, Sphingosine 1-phosphate receptor 5 (S1PR5) Kit
产品名称：EZElisa™鞘氨醇1磷酸受体3（S1PR3）试剂盒-EZElisa™ Sphingosine 1-phosphate receptor 5 (S1PR5) Kit
产品货号：A-QEK01029-96wells
产品规格：96wells
Enzyme Immunoassay for the estimation of EZElisa™ Sphingosine 1 - phosphate receptor 5 (S1PR5) in serum and plasma, tissue homogenates and other biological fluids.
种属：Human
检测方法：比色法
检测范围：78.125 - 5000 pg/ml
该EZElisa™鞘氨醇1-磷酸受体5（S1 PR 5）试剂盒ELISA的特点包括：即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证，符合金环标准质量ELISA的要求，这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物，样品可以是血清
运输过程中保存：2-8℃
点击：EZElisa™鞘氨醇1磷酸受体3（S1PR3）试剂盒-EZElisa™ Sphingosine 1-phosphate receptor 5 (S1PR5) Kit更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Sphingosine-1-phosphate (S1P) is a bioactive lipid mediator involved in many biological actions, including vascular homeostasis and immune cell trafficking. S1P activity is mediated by specific G protein-coupled receptors, leading to multiple
Measuring the effects of sphingosine-1-phosphate (S1P) receptor modulators on human primary neural cells is of particular interest given the recent application of these central nervous system-accessible agents to the treatment
Pharmacology, Biodistribution, and Efficacy of GPCR-Based Pepducins in Disease Models
against a wide variety of GPCRs including the protease-activated receptors (PAR1, 2, 4), the chemokine receptors (CXCR1, 2, 4), the sphingosine-1-phosphate receptor (S1P3), the adrenergic receptor (ADRA1B), and have the potential to help reveal the functions
技术资料暂无技术资料 索取技术资料
